| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Y Chromosome | 100 | 2023 | 205 | 12.620 |
Why?
|
| Chromosomes, Human, Y | 29 | 2024 | 161 | 7.810 |
Why?
|
| Germ Cells | 29 | 2021 | 635 | 7.010 |
Why?
|
| X Chromosome | 69 | 2024 | 815 | 5.600 |
Why?
|
| Meiosis | 29 | 2024 | 328 | 4.350 |
Why?
|
| Spermatogenesis | 31 | 2024 | 257 | 4.110 |
Why?
|
| Testis | 44 | 2020 | 794 | 3.610 |
Why?
|
| Evolution, Molecular | 27 | 2021 | 1885 | 3.230 |
Why?
|
| RNA-Binding Proteins | 22 | 2024 | 1894 | 2.570 |
Why?
|
| Pan troglodytes | 10 | 2021 | 224 | 2.200 |
Why?
|
| Ovary | 20 | 2019 | 958 | 2.110 |
Why?
|
| Tretinoin | 9 | 2024 | 519 | 2.100 |
Why?
|
| Spermatogonia | 9 | 2024 | 30 | 2.060 |
Why?
|
| Oligospermia | 17 | 2022 | 59 | 2.010 |
Why?
|
| Mammals | 12 | 2022 | 1132 | 1.880 |
Why?
|
| Gametogenesis | 6 | 2021 | 26 | 1.880 |
Why?
|
| Gene Expression Regulation, Developmental | 24 | 2024 | 3602 | 1.790 |
Why?
|
| Chromosome Deletion | 25 | 2012 | 1387 | 1.690 |
Why?
|
| Sex Chromosomes | 11 | 2022 | 101 | 1.660 |
Why?
|
| Sex Chromosome Aberrations | 18 | 2023 | 116 | 1.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 15 | 2024 | 2895 | 1.420 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11471 | 1.410 |
Why?
|
| Chromosome Mapping | 56 | 2024 | 4624 | 1.410 |
Why?
|
| Turner Syndrome | 13 | 2019 | 130 | 1.380 |
Why?
|
| Gene Dosage | 6 | 2018 | 1218 | 1.330 |
Why?
|
| Spermatozoa | 16 | 2019 | 631 | 1.310 |
Why?
|
| Genes | 20 | 2010 | 1845 | 1.300 |
Why?
|
| Chromosomes, Human, X | 8 | 2024 | 321 | 1.290 |
Why?
|
| Selection, Genetic | 6 | 2021 | 868 | 1.280 |
Why?
|
| Sequence Analysis, DNA | 16 | 2022 | 4711 | 1.260 |
Why?
|
| Malocclusion | 9 | 2010 | 131 | 1.240 |
Why?
|
| Orthodontic Appliances, Functional | 6 | 2004 | 12 | 1.170 |
Why?
|
| Sex Determination Processes | 6 | 2017 | 59 | 1.130 |
Why?
|
| Gonads | 7 | 2019 | 109 | 1.080 |
Why?
|
| Biological Evolution | 9 | 2015 | 1074 | 1.080 |
Why?
|
| Orthodontics, Interceptive | 6 | 2004 | 8 | 1.050 |
Why?
|
| Gene Conversion | 3 | 2021 | 67 | 1.040 |
Why?
|
| Embryo, Mammalian | 10 | 2019 | 1674 | 1.000 |
Why?
|
| Crossing Over, Genetic | 9 | 2024 | 95 | 0.980 |
Why?
|
| Gene Deletion | 11 | 2015 | 2666 | 0.980 |
Why?
|
| Macaca mulatta | 6 | 2022 | 2316 | 0.970 |
Why?
|
| Animals | 139 | 2024 | 167768 | 0.960 |
Why?
|
| Oogenesis | 5 | 2013 | 124 | 0.950 |
Why?
|
| Nanopores | 2 | 2022 | 44 | 0.950 |
Why?
|
| Recombination, Genetic | 19 | 2015 | 1526 | 0.950 |
Why?
|
| Spermatocytes | 6 | 2019 | 40 | 0.920 |
Why?
|
| Sex Determination Analysis | 19 | 1994 | 46 | 0.910 |
Why?
|
| Mice | 89 | 2024 | 81101 | 0.900 |
Why?
|
| Infertility, Male | 13 | 2022 | 396 | 0.890 |
Why?
|
| Sex Characteristics | 8 | 2019 | 2621 | 0.880 |
Why?
|
| Orthodontics, Preventive | 4 | 2010 | 5 | 0.840 |
Why?
|
| Molecular Sequence Data | 62 | 2014 | 17617 | 0.830 |
Why?
|
| Conserved Sequence | 6 | 2019 | 1165 | 0.830 |
Why?
|
| Multigene Family | 17 | 2010 | 1076 | 0.830 |
Why?
|
| Oocytes | 5 | 2019 | 1165 | 0.830 |
Why?
|
| Proteins | 20 | 2013 | 6026 | 0.780 |
Why?
|
| Base Sequence | 54 | 2019 | 12436 | 0.770 |
Why?
|
| Maxillofacial Development | 7 | 2010 | 87 | 0.760 |
Why?
|
| Genes, Y-Linked | 2 | 2020 | 12 | 0.750 |
Why?
|
| Chromosomes, Mammalian | 2 | 2014 | 146 | 0.670 |
Why?
|
| Wills | 1 | 2019 | 13 | 0.670 |
Why?
|
| Translocation, Genetic | 15 | 2019 | 1387 | 0.660 |
Why?
|
| Transcription Factors | 23 | 2023 | 12094 | 0.660 |
Why?
|
| Male | 177 | 2024 | 358747 | 0.650 |
Why?
|
| Inverted Repeat Sequences | 3 | 2021 | 60 | 0.630 |
Why?
|
| Genomics | 6 | 2024 | 5790 | 0.630 |
Why?
|
| Transcription Factor TFIID | 4 | 2022 | 153 | 0.630 |
Why?
|
| Genome, Human | 10 | 2024 | 4416 | 0.620 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3754 | 0.610 |
Why?
|
| Prophase | 2 | 2017 | 16 | 0.610 |
Why?
|
| Hominidae | 4 | 2012 | 68 | 0.610 |
Why?
|
| Genetic Linkage | 14 | 2005 | 2381 | 0.600 |
Why?
|
| Sequence Tagged Sites | 12 | 2007 | 94 | 0.600 |
Why?
|
| DNA | 34 | 2019 | 7199 | 0.600 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 9404 | 0.590 |
Why?
|
| Cyclin A2 | 1 | 2017 | 21 | 0.580 |
Why?
|
| Chromosomes | 3 | 2018 | 575 | 0.570 |
Why?
|
| Chromatin | 5 | 2023 | 2938 | 0.570 |
Why?
|
| Ribosomal Proteins | 8 | 1998 | 363 | 0.570 |
Why?
|
| Gene Expression Regulation | 12 | 2023 | 11892 | 0.570 |
Why?
|
| Histone Demethylases | 2 | 2019 | 319 | 0.570 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2017 | 146 | 0.560 |
Why?
|
| Nuclear Proteins | 10 | 2019 | 5786 | 0.560 |
Why?
|
| Sequence Homology, Nucleic Acid | 21 | 2010 | 1055 | 0.560 |
Why?
|
| Birds | 2 | 2017 | 168 | 0.560 |
Why?
|
| GATA4 Transcription Factor | 3 | 2015 | 124 | 0.560 |
Why?
|
| TATA-Binding Protein Associated Factors | 3 | 2022 | 103 | 0.550 |
Why?
|
| Mutagenesis, Insertional | 2 | 2019 | 652 | 0.550 |
Why?
|
| Chickens | 5 | 2018 | 860 | 0.550 |
Why?
|
| Genes, Developmental | 1 | 2016 | 38 | 0.540 |
Why?
|
| Models, Biological | 6 | 2021 | 9460 | 0.540 |
Why?
|
| Dosage Compensation, Genetic | 9 | 1998 | 207 | 0.530 |
Why?
|
| Antigens, Nuclear | 1 | 2016 | 184 | 0.530 |
Why?
|
| Meiotic Prophase I | 1 | 2015 | 7 | 0.520 |
Why?
|
| DNA-Binding Proteins | 24 | 2019 | 9574 | 0.520 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 494 | 0.520 |
Why?
|
| Mitosis | 5 | 2019 | 1191 | 0.520 |
Why?
|
| X Chromosome Inactivation | 1 | 2018 | 226 | 0.520 |
Why?
|
| Transgenes | 1 | 2019 | 1007 | 0.510 |
Why?
|
| Genes, Regulator | 1 | 2016 | 374 | 0.500 |
Why?
|
| Pluripotent Stem Cells | 4 | 2019 | 792 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 3615 | 0.490 |
Why?
|
| Genitalia, Male | 3 | 2013 | 87 | 0.490 |
Why?
|
| Sex Differentiation | 7 | 1999 | 73 | 0.480 |
Why?
|
| Phylogeny | 8 | 2018 | 2774 | 0.480 |
Why?
|
| Databases, Nucleic Acid | 3 | 2007 | 204 | 0.480 |
Why?
|
| Genes, X-Linked | 5 | 2022 | 128 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 18 | 2020 | 22003 | 0.460 |
Why?
|
| Organ Specificity | 10 | 2020 | 1955 | 0.460 |
Why?
|
| DNA Replication | 5 | 2019 | 1410 | 0.460 |
Why?
|
| Vertebrates | 2 | 2018 | 228 | 0.460 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2013 | 3 | 0.450 |
Why?
|
| Cattle | 5 | 2022 | 3845 | 0.450 |
Why?
|
| Totipotent Stem Cells | 1 | 2013 | 16 | 0.450 |
Why?
|
| Disorders of Sex Development | 7 | 2003 | 128 | 0.450 |
Why?
|
| Genitalia, Female | 2 | 2013 | 147 | 0.440 |
Why?
|
| DNA Copy Number Variations | 3 | 2019 | 2012 | 0.440 |
Why?
|
| Gene Regulatory Networks | 4 | 2023 | 1740 | 0.440 |
Why?
|
| Gene Expression | 9 | 2023 | 7583 | 0.430 |
Why?
|
| In Situ Hybridization, Fluorescence | 14 | 2019 | 2504 | 0.430 |
Why?
|
| Cell Cycle Proteins | 6 | 2017 | 3442 | 0.420 |
Why?
|
| Sheep | 1 | 2015 | 1441 | 0.420 |
Why?
|
| Orthodontics | 2 | 2005 | 78 | 0.410 |
Why?
|
| Reproduction | 1 | 2016 | 646 | 0.400 |
Why?
|
| Humans | 188 | 2024 | 758406 | 0.390 |
Why?
|
| Gene Duplication | 6 | 2018 | 313 | 0.380 |
Why?
|
| Female | 117 | 2024 | 390323 | 0.380 |
Why?
|
| Cell Movement | 4 | 2021 | 5201 | 0.380 |
Why?
|
| Cell Cycle | 2 | 2019 | 2930 | 0.370 |
Why?
|
| Metalloproteins | 6 | 1990 | 101 | 0.370 |
Why?
|
| Emergency Medical Technicians | 1 | 2011 | 119 | 0.370 |
Why?
|
| Gene Amplification | 8 | 2020 | 1085 | 0.360 |
Why?
|
| Flow Cytometry | 3 | 2018 | 5864 | 0.360 |
Why?
|
| Genetics | 1 | 2011 | 114 | 0.360 |
Why?
|
| Epigenomics | 1 | 2016 | 936 | 0.350 |
Why?
|
| Sequence Alignment | 9 | 2015 | 2176 | 0.350 |
Why?
|
| Bayes Theorem | 7 | 2014 | 2322 | 0.350 |
Why?
|
| Sequence Deletion | 7 | 2013 | 1492 | 0.340 |
Why?
|
| Retinoblastoma Protein | 1 | 2013 | 670 | 0.340 |
Why?
|
| Histones | 4 | 2016 | 2577 | 0.330 |
Why?
|
| Data Mining | 1 | 2014 | 551 | 0.330 |
Why?
|
| Artificial Intelligence | 4 | 2014 | 2551 | 0.320 |
Why?
|
| Genome | 5 | 2019 | 1739 | 0.320 |
Why?
|
| Models, Genetic | 12 | 2012 | 3441 | 0.320 |
Why?
|
| Cell Nucleus | 6 | 2023 | 2907 | 0.320 |
Why?
|
| Fetus | 3 | 2013 | 1859 | 0.320 |
Why?
|
| Centromere | 6 | 2016 | 213 | 0.320 |
Why?
|
| Seminal Plasma Proteins | 3 | 2004 | 11 | 0.310 |
Why?
|
| Zinc Fingers | 7 | 1997 | 568 | 0.310 |
Why?
|
| Faculty | 1 | 2011 | 383 | 0.310 |
Why?
|
| Orthodontics, Corrective | 3 | 2002 | 77 | 0.310 |
Why?
|
| Phosphoproteins | 2 | 2014 | 2433 | 0.290 |
Why?
|
| Noonan Syndrome | 7 | 1990 | 120 | 0.290 |
Why?
|
| MicroRNAs | 3 | 2020 | 3783 | 0.280 |
Why?
|
| Species Specificity | 10 | 2016 | 2417 | 0.280 |
Why?
|
| DNA Transposable Elements | 4 | 2003 | 756 | 0.280 |
Why?
|
| Ovum | 2 | 2007 | 187 | 0.280 |
Why?
|
| Klinefelter Syndrome | 2 | 2003 | 47 | 0.280 |
Why?
|
| Physical Chromosome Mapping | 3 | 2001 | 182 | 0.270 |
Why?
|
| Respiratory System | 1 | 2010 | 557 | 0.270 |
Why?
|
| Haplotypes | 4 | 2022 | 2764 | 0.270 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 895 | 0.270 |
Why?
|
| Opossums | 2 | 2016 | 104 | 0.260 |
Why?
|
| Introns | 8 | 2009 | 978 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 20 | 2012 | 6068 | 0.260 |
Why?
|
| Computational Biology | 5 | 2020 | 3502 | 0.250 |
Why?
|
| Chromosome Pairing | 3 | 2017 | 45 | 0.250 |
Why?
|
| Licensure, Dental | 1 | 2004 | 19 | 0.250 |
Why?
|
| DNA Primers | 10 | 2011 | 2816 | 0.250 |
Why?
|
| Spermatids | 4 | 2017 | 36 | 0.240 |
Why?
|
| Transcription, Genetic | 16 | 2014 | 7590 | 0.240 |
Why?
|
| Mammography | 5 | 2014 | 2427 | 0.240 |
Why?
|
| Cloning, Molecular | 18 | 2005 | 4169 | 0.230 |
Why?
|
| Myofunctional Therapy | 2 | 2001 | 2 | 0.230 |
Why?
|
| Nucleic Acid Hybridization | 21 | 1990 | 1304 | 0.230 |
Why?
|
| Polymorphism, Genetic | 15 | 2006 | 4284 | 0.230 |
Why?
|
| Transducin | 1 | 2003 | 42 | 0.220 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 411 | 0.220 |
Why?
|
| Gonadal Dysgenesis | 3 | 1995 | 28 | 0.220 |
Why?
|
| Euchromatin | 4 | 2005 | 54 | 0.220 |
Why?
|
| Teratoma | 2 | 2019 | 403 | 0.220 |
Why?
|
| Testicular Neoplasms | 3 | 2019 | 801 | 0.220 |
Why?
|
| Respiration | 1 | 2010 | 1654 | 0.220 |
Why?
|
| Mice, Mutant Strains | 6 | 2013 | 1751 | 0.210 |
Why?
|
| Biological Factors | 1 | 2004 | 157 | 0.210 |
Why?
|
| Abnormalities, Multiple | 4 | 2003 | 1414 | 0.210 |
Why?
|
| Imidoesters | 1 | 2022 | 2 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10416 | 0.200 |
Why?
|
| Signal Transduction | 6 | 2017 | 23342 | 0.200 |
Why?
|
| Education, Dental | 1 | 2004 | 221 | 0.200 |
Why?
|
| Dysgerminoma | 2 | 1995 | 66 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 2002 | 783 | 0.200 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2002 | 156 | 0.200 |
Why?
|
| Mosaicism | 7 | 2001 | 465 | 0.190 |
Why?
|
| Amino Acid Sequence | 19 | 2002 | 13447 | 0.190 |
Why?
|
| Gene Library | 5 | 2018 | 1059 | 0.190 |
Why?
|
| Sequence Homology | 3 | 2014 | 195 | 0.190 |
Why?
|
| Embryonic Development | 3 | 2013 | 716 | 0.190 |
Why?
|
| Exons | 8 | 2013 | 2387 | 0.190 |
Why?
|
| Acetyltransferases | 1 | 2002 | 231 | 0.190 |
Why?
|
| Philosophy, Dental | 1 | 2000 | 5 | 0.190 |
Why?
|
| Karyotyping | 15 | 2012 | 1171 | 0.190 |
Why?
|
| Breast Feeding | 4 | 2004 | 1355 | 0.190 |
Why?
|
| Sex Chromosome Disorders | 2 | 2011 | 8 | 0.180 |
Why?
|
| Gonadoblastoma | 3 | 1995 | 14 | 0.180 |
Why?
|
| Mice, Knockout | 10 | 2017 | 14354 | 0.180 |
Why?
|
| Stem Cells | 2 | 2013 | 3521 | 0.180 |
Why?
|
| Chromosome Segregation | 2 | 2019 | 233 | 0.180 |
Why?
|
| Binding Sites | 6 | 2019 | 6036 | 0.180 |
Why?
|
| Pituitary Gland | 1 | 2003 | 637 | 0.180 |
Why?
|
| Algorithms | 7 | 2014 | 13961 | 0.180 |
Why?
|
| Genetic Research | 2 | 2015 | 172 | 0.170 |
Why?
|
| Polymorphism, Restriction Fragment Length | 12 | 1992 | 763 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 17768 | 0.170 |
Why?
|
| Emergency Medical Services | 1 | 2011 | 1915 | 0.170 |
Why?
|
| RNA, Messenger | 10 | 2024 | 12759 | 0.170 |
Why?
|
| Fibroblasts | 5 | 2019 | 4087 | 0.170 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 706 | 0.170 |
Why?
|
| Circle of Willis | 1 | 2019 | 79 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 4 | 2013 | 3796 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 6 | 2019 | 5779 | 0.170 |
Why?
|
| Anterior Cerebral Artery | 1 | 2019 | 50 | 0.170 |
Why?
|
| Endogenous Retroviruses | 1 | 2000 | 111 | 0.170 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2014 | 122 | 0.170 |
Why?
|
| Mutation | 15 | 2022 | 29915 | 0.170 |
Why?
|
| Chromosomes, Artificial, Yeast | 6 | 2000 | 113 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2016 | 727 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2003 | 1130 | 0.160 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2019 | 122 | 0.160 |
Why?
|
| Cytoplasm | 2 | 2000 | 1514 | 0.160 |
Why?
|
| DNA, Complementary | 10 | 1999 | 1991 | 0.160 |
Why?
|
| Crosses, Genetic | 4 | 2015 | 751 | 0.150 |
Why?
|
| Pachytene Stage | 1 | 2017 | 2 | 0.150 |
Why?
|
| Genetic Privacy | 1 | 1998 | 60 | 0.150 |
Why?
|
| Insemination, Artificial | 1 | 1998 | 99 | 0.150 |
Why?
|
| Macaca fascicularis | 2 | 2019 | 900 | 0.150 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 514 | 0.150 |
Why?
|
| Radiation Hybrid Mapping | 2 | 2012 | 18 | 0.150 |
Why?
|
| Cercopithecidae | 2 | 2012 | 22 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 7 | 1998 | 503 | 0.150 |
Why?
|
| Caenorhabditis elegans | 3 | 2019 | 1444 | 0.150 |
Why?
|
| Primates | 2 | 2014 | 523 | 0.150 |
Why?
|
| Mouth Breathing | 2 | 2010 | 19 | 0.150 |
Why?
|
| Retinal Dehydrogenase | 1 | 2017 | 78 | 0.150 |
Why?
|
| Complementary Therapies | 1 | 2002 | 486 | 0.150 |
Why?
|
| Point Mutation | 3 | 1999 | 1593 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2004 | 1248 | 0.150 |
Why?
|
| Human Genome Project | 5 | 1998 | 199 | 0.140 |
Why?
|
| DNA Probes | 8 | 2008 | 543 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2015 | 2904 | 0.140 |
Why?
|
| Dogs | 2 | 2019 | 3840 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2014 | 4761 | 0.140 |
Why?
|
| DNA Restriction Enzymes | 10 | 1987 | 553 | 0.140 |
Why?
|
| Marsupialia | 2 | 2014 | 20 | 0.140 |
Why?
|
| Mice, Inbred Strains | 4 | 2012 | 1759 | 0.140 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2016 | 38 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 3 | 1998 | 601 | 0.140 |
Why?
|
| Face | 1 | 2003 | 1017 | 0.140 |
Why?
|
| Pseudogenes | 4 | 2005 | 103 | 0.140 |
Why?
|
| Cell Line | 12 | 2018 | 15591 | 0.140 |
Why?
|
| Hybrid Cells | 9 | 1998 | 422 | 0.140 |
Why?
|
| H-Y Antigen | 3 | 2000 | 42 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 2001 | 0.130 |
Why?
|
| Cell Lineage | 2 | 2020 | 2533 | 0.130 |
Why?
|
| Chromosome Aberrations | 4 | 2019 | 1763 | 0.130 |
Why?
|
| Databases, Factual | 7 | 2017 | 7980 | 0.130 |
Why?
|
| Genetic Diseases, Y-Linked | 1 | 2015 | 1 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2019 | 1527 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2008 | 5070 | 0.130 |
Why?
|
| Eukaryota | 1 | 2016 | 100 | 0.130 |
Why?
|
| Azoospermia | 1 | 2015 | 28 | 0.130 |
Why?
|
| Genetics, Medical | 1 | 1998 | 336 | 0.130 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2015 | 31 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 1987 | 362 | 0.130 |
Why?
|
| Protein Binding | 4 | 2019 | 9311 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2019 | 704 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 15773 | 0.130 |
Why?
|
| Hearing Disorders | 1 | 2015 | 126 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4567 | 0.120 |
Why?
|
| Histone Acetyltransferases | 3 | 2002 | 337 | 0.120 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2015 | 85 | 0.120 |
Why?
|
| Gene Rearrangement | 2 | 2019 | 1122 | 0.120 |
Why?
|
| Genetic Markers | 17 | 2000 | 2608 | 0.120 |
Why?
|
| Monocytes | 1 | 2024 | 2570 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2014 | 84 | 0.120 |
Why?
|
| Phenotype | 10 | 2019 | 16534 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 2753 | 0.120 |
Why?
|
| CpG Islands | 2 | 1998 | 1221 | 0.120 |
Why?
|
| RNA, Small Nuclear | 1 | 1995 | 74 | 0.120 |
Why?
|
| Sexual Maturation | 1 | 1996 | 260 | 0.120 |
Why?
|
| Microglia | 1 | 2023 | 1349 | 0.120 |
Why?
|
| Ethics, Medical | 2 | 2004 | 783 | 0.120 |
Why?
|
| Infertility, Female | 3 | 2014 | 759 | 0.120 |
Why?
|
| Virilism | 1 | 1994 | 28 | 0.120 |
Why?
|
| Sister Chromatid Exchange | 2 | 2013 | 60 | 0.110 |
Why?
|
| Contig Mapping | 2 | 2012 | 54 | 0.110 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 488 | 0.110 |
Why?
|
| Fertilization in Vitro | 2 | 1999 | 1292 | 0.110 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 223 | 0.110 |
Why?
|
| Chromosome Banding | 12 | 1992 | 260 | 0.110 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2013 | 13 | 0.110 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2014 | 198 | 0.110 |
Why?
|
| SOXB2 Transcription Factors | 1 | 2013 | 2 | 0.110 |
Why?
|
| Pedigree | 11 | 2004 | 4578 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 410 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 1309 | 0.110 |
Why?
|
| Rats | 4 | 2019 | 23679 | 0.110 |
Why?
|
| Tunisia | 1 | 2012 | 36 | 0.110 |
Why?
|
| Cell Division | 1 | 2000 | 4458 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2013 | 837 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2003 | 4215 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2004 | 2980 | 0.110 |
Why?
|
| Protein Biosynthesis | 4 | 2014 | 2105 | 0.100 |
Why?
|
| Sertoli Cells | 1 | 2012 | 50 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1851 | 0.100 |
Why?
|
| Follistatin | 2 | 2004 | 137 | 0.100 |
Why?
|
| Ovulation | 1 | 2013 | 181 | 0.100 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 4 | 1999 | 10 | 0.100 |
Why?
|
| Drugs, Generic | 1 | 2017 | 444 | 0.100 |
Why?
|
| Poland | 1 | 2012 | 196 | 0.100 |
Why?
|
| RNA Splicing | 2 | 1994 | 913 | 0.100 |
Why?
|
| Gorilla gorilla | 2 | 2003 | 29 | 0.100 |
Why?
|
| Fertilization | 1 | 2013 | 197 | 0.100 |
Why?
|
| Protein Stability | 1 | 2014 | 566 | 0.100 |
Why?
|
| Ovarian Neoplasms | 3 | 2019 | 4876 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 3563 | 0.100 |
Why?
|
| Early Diagnosis | 2 | 2010 | 1177 | 0.100 |
Why?
|
| Vietnam | 1 | 2012 | 410 | 0.100 |
Why?
|
| Breast Neoplasms | 5 | 2014 | 21017 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4353 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1842 | 0.100 |
Why?
|
| Embryo Loss | 1 | 2011 | 55 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 524 | 0.100 |
Why?
|
| Ovarian Follicle | 1 | 2013 | 244 | 0.100 |
Why?
|
| Dental Arch | 2 | 2002 | 43 | 0.100 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 5079 | 0.090 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 1999 | 220 | 0.090 |
Why?
|
| Health | 1 | 2014 | 398 | 0.090 |
Why?
|
| Bottle Feeding | 2 | 2001 | 67 | 0.090 |
Why?
|
| Neoplasms | 2 | 2019 | 22032 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1074 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 311 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 857 | 0.090 |
Why?
|
| Endonucleases | 1 | 2013 | 369 | 0.090 |
Why?
|
| Animals, Newborn | 4 | 2011 | 2672 | 0.090 |
Why?
|
| Airway Obstruction | 2 | 2010 | 661 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 9518 | 0.090 |
Why?
|
| Microtubules | 1 | 2016 | 1072 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 2 | 2001 | 180 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2001 | 315 | 0.090 |
Why?
|
| Logic | 2 | 2012 | 40 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2014 | 23884 | 0.090 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 11070 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2008 | 6910 | 0.090 |
Why?
|
| Decision Trees | 2 | 2008 | 504 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1745 | 0.080 |
Why?
|
| Restriction Mapping | 5 | 2000 | 852 | 0.080 |
Why?
|
| Child, Preschool | 13 | 2010 | 42062 | 0.080 |
Why?
|
| Heterochromatin | 2 | 2003 | 293 | 0.080 |
Why?
|
| Swine | 1 | 2019 | 5892 | 0.080 |
Why?
|
| Penetrance | 1 | 2011 | 388 | 0.080 |
Why?
|
| Densitometry | 1 | 2009 | 151 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2010 | 228 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2003 | 725 | 0.080 |
Why?
|
| Metabolome | 1 | 2016 | 982 | 0.080 |
Why?
|
| Muridae | 4 | 1996 | 56 | 0.080 |
Why?
|
| Luteinizing Hormone | 2 | 2003 | 820 | 0.080 |
Why?
|
| DNA Breaks | 1 | 2008 | 47 | 0.080 |
Why?
|
| Esterases | 1 | 2008 | 97 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2004 | 4775 | 0.080 |
Why?
|
| Airway Resistance | 1 | 2010 | 400 | 0.080 |
Why?
|
| Zinc | 2 | 1990 | 687 | 0.080 |
Why?
|
| Maxilla | 2 | 2003 | 491 | 0.080 |
Why?
|
| DNA Repair | 3 | 2019 | 2038 | 0.080 |
Why?
|
| Facial Bones | 1 | 2010 | 205 | 0.080 |
Why?
|
| Disease | 1 | 2014 | 671 | 0.080 |
Why?
|
| Chromosomal Instability | 1 | 2009 | 177 | 0.080 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2013 | 293 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 1808 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6209 | 0.070 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2008 | 93 | 0.070 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2007 | 21 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 1 | 2008 | 164 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3069 | 0.070 |
Why?
|
| Chromosome Inversion | 2 | 2013 | 120 | 0.070 |
Why?
|
| Mandible | 2 | 2003 | 750 | 0.070 |
Why?
|
| Nucleotides | 1 | 2009 | 450 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2011 | 359 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 2413 | 0.070 |
Why?
|
| Blotting, Southern | 6 | 2000 | 777 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 1988 | 442 | 0.070 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1543 | 0.070 |
Why?
|
| Open Reading Frames | 2 | 2004 | 814 | 0.070 |
Why?
|
| Pregnancy | 10 | 2007 | 29742 | 0.070 |
Why?
|
| DNA Methylation | 3 | 2014 | 4373 | 0.070 |
Why?
|
| Body Weight | 1 | 1997 | 4603 | 0.070 |
Why?
|
| Child | 12 | 2010 | 79818 | 0.070 |
Why?
|
| Ligands | 1 | 2013 | 3258 | 0.070 |
Why?
|
| Nose | 1 | 2010 | 519 | 0.070 |
Why?
|
| Ovarian Diseases | 1 | 1987 | 137 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 4673 | 0.070 |
Why?
|
| India | 1 | 2012 | 2329 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2011 | 4485 | 0.060 |
Why?
|
| Sex-Determining Region Y Protein | 2 | 1996 | 15 | 0.060 |
Why?
|
| Vitamin A Deficiency | 1 | 2006 | 88 | 0.060 |
Why?
|
| Choroid | 1 | 1988 | 349 | 0.060 |
Why?
|
| Cholesterol | 1 | 2014 | 2902 | 0.060 |
Why?
|
| Sex Factors | 1 | 2019 | 10504 | 0.060 |
Why?
|
| Adult | 25 | 2019 | 219935 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 936 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5484 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 609 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 403 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2006 | 354 | 0.060 |
Why?
|
| Infertility | 1 | 2011 | 655 | 0.060 |
Why?
|
| Interphase | 2 | 2004 | 228 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 281 | 0.060 |
Why?
|
| Pan paniscus | 1 | 2003 | 5 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1987 | 701 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2004 | 91 | 0.060 |
Why?
|
| Haploidy | 1 | 2003 | 133 | 0.060 |
Why?
|
| RNA Helicases | 1 | 2024 | 146 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 1710 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2004 | 184 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2023 | 2564 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2007 | 699 | 0.050 |
Why?
|
| Orthodontic Appliance Design | 1 | 2003 | 53 | 0.050 |
Why?
|
| Hormones | 2 | 2002 | 869 | 0.050 |
Why?
|
| Inhibins | 1 | 2003 | 209 | 0.050 |
Why?
|
| Organogenesis | 1 | 2004 | 215 | 0.050 |
Why?
|
| TATA-Box Binding Protein | 1 | 2002 | 99 | 0.050 |
Why?
|
| Microinjections | 2 | 2003 | 321 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18119 | 0.050 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2004 | 159 | 0.050 |
Why?
|
| Paternal Age | 1 | 2002 | 87 | 0.050 |
Why?
|
| Infant | 7 | 2003 | 36055 | 0.050 |
Why?
|
| Operon | 1 | 2003 | 370 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 1214 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 388 | 0.050 |
Why?
|
| Internet | 2 | 2007 | 3082 | 0.050 |
Why?
|
| Health Education, Dental | 1 | 2002 | 26 | 0.050 |
Why?
|
| RNA Stability | 1 | 2024 | 331 | 0.050 |
Why?
|
| Blood Donors | 1 | 2004 | 343 | 0.050 |
Why?
|
| Oligonucleotide Probes | 3 | 1991 | 416 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2003 | 346 | 0.050 |
Why?
|
| Breast Diseases | 1 | 2005 | 443 | 0.050 |
Why?
|
| Fingersucking | 1 | 2001 | 4 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2016 | 1632 | 0.050 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2001 | 73 | 0.050 |
Why?
|
| Muscular Dystrophies | 1 | 1983 | 389 | 0.050 |
Why?
|
| Time Factors | 3 | 2012 | 39872 | 0.050 |
Why?
|
| Cleft Palate | 2 | 2003 | 587 | 0.050 |
Why?
|
| Sucking Behavior | 1 | 2001 | 28 | 0.050 |
Why?
|
| Fertility | 3 | 2011 | 773 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2007 | 1397 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2131 | 0.050 |
Why?
|
| Genetic Variation | 3 | 2009 | 6548 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2009 | 3156 | 0.050 |
Why?
|
| Pamphlets | 1 | 2001 | 71 | 0.050 |
Why?
|
| Karyopherins | 1 | 2001 | 130 | 0.050 |
Why?
|
| RNA Interference | 1 | 2009 | 2836 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2000 | 144 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2007 | 1168 | 0.040 |
Why?
|
| HLA-B8 Antigen | 1 | 2000 | 18 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2003 | 2262 | 0.040 |
Why?
|
| Cell Count | 2 | 2011 | 1835 | 0.040 |
Why?
|
| Chromosome Disorders | 2 | 1994 | 499 | 0.040 |
Why?
|
| Genomic Library | 1 | 2000 | 189 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 2000 | 159 | 0.040 |
Why?
|
| Nondisjunction, Genetic | 2 | 1991 | 24 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2022 | 576 | 0.040 |
Why?
|
| Cells, Cultured | 8 | 2019 | 18940 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 2003 | 26183 | 0.040 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1694 | 0.040 |
Why?
|
| Monkey Diseases | 1 | 1999 | 71 | 0.040 |
Why?
|
| Acetylation | 1 | 2002 | 1060 | 0.040 |
Why?
|
| Infant Care | 1 | 2001 | 180 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 280 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 821 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2003 | 1233 | 0.040 |
Why?
|
| Hydro-Lyases | 1 | 1999 | 93 | 0.040 |
Why?
|
| Age Factors | 4 | 2012 | 18358 | 0.040 |
Why?
|
| Enuresis | 1 | 1999 | 50 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 2001 | 372 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1900 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 1998 | 53 | 0.040 |
Why?
|
| Syndrome | 2 | 2003 | 3262 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2000 | 330 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 1999 | 191 | 0.040 |
Why?
|
| Third-Party Consent | 1 | 1998 | 66 | 0.040 |
Why?
|
| Cricetinae | 3 | 1995 | 2426 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2014 | 4113 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1999 | 193 | 0.040 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1998 | 110 | 0.040 |
Why?
|
| Sperm Count | 1 | 1998 | 228 | 0.040 |
Why?
|
| Surface Properties | 1 | 2001 | 1159 | 0.040 |
Why?
|
| Litter Size | 2 | 2007 | 49 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2000 | 383 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 1705 | 0.040 |
Why?
|
| Centromere Protein B | 1 | 2016 | 3 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2005 | 5031 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 534 | 0.040 |
Why?
|
| DNA Damage | 2 | 2019 | 2439 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1998 | 240 | 0.040 |
Why?
|
| Biopsy | 2 | 2009 | 6768 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 3425 | 0.040 |
Why?
|
| Law Enforcement | 1 | 1998 | 112 | 0.040 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 1997 | 105 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 855 | 0.030 |
Why?
|
| Genetic Loci | 2 | 2004 | 2612 | 0.030 |
Why?
|
| Mothers | 1 | 2007 | 2189 | 0.030 |
Why?
|
| Federal Government | 1 | 1998 | 267 | 0.030 |
Why?
|
| Otitis Media | 1 | 1999 | 285 | 0.030 |
Why?
|
| Research Subjects | 1 | 1998 | 249 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2690 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2004 | 1129 | 0.030 |
Why?
|
| Homozygote | 3 | 1997 | 1788 | 0.030 |
Why?
|
| DNA Fingerprinting | 2 | 1994 | 111 | 0.030 |
Why?
|
| Estradiol | 1 | 2003 | 1933 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2002 | 1434 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 1998 | 649 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15651 | 0.030 |
Why?
|
| Fetal Death | 1 | 1997 | 434 | 0.030 |
Why?
|
| Software | 2 | 2005 | 4415 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2016 | 5410 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 266 | 0.030 |
Why?
|
| Strontium | 1 | 2014 | 21 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1295 | 0.030 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 1262 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2019 | 965 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 2014 | 169 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1065 | 0.030 |
Why?
|
| Alleles | 6 | 1994 | 6895 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2014 | 68 | 0.030 |
Why?
|
| Information Theory | 1 | 2014 | 49 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6234 | 0.030 |
Why?
|
| Macrophages | 1 | 2009 | 5737 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 2011 | 555 | 0.030 |
Why?
|
| Prejudice | 1 | 1998 | 571 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 1655 | 0.030 |
Why?
|
| Government Regulation | 1 | 1998 | 524 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5199 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 342 | 0.030 |
Why?
|
| Neonatal Screening | 1 | 1998 | 594 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1997 | 551 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 825 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 116 | 0.030 |
Why?
|
| Isochromosomes | 1 | 2013 | 16 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 491 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 5781 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 1994 | 160 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1994 | 210 | 0.030 |
Why?
|
| Monosomy | 1 | 1993 | 52 | 0.030 |
Why?
|
| Genotype | 3 | 2013 | 12945 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2716 | 0.030 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 45 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 1431 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15225 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 1080 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 1539 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 322 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 232 | 0.030 |
Why?
|
| Testosterone | 1 | 2003 | 2471 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 877 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2002 | 4938 | 0.030 |
Why?
|
| United States | 3 | 2017 | 72136 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2012 | 239 | 0.030 |
Why?
|
| Heterozygote | 2 | 1997 | 2797 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2014 | 956 | 0.030 |
Why?
|
| Proteomics | 1 | 2006 | 3816 | 0.030 |
Why?
|
| Cosmids | 1 | 1991 | 105 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1994 | 981 | 0.020 |
Why?
|
| Tetraploidy | 1 | 2011 | 28 | 0.020 |
Why?
|
| Drug Industry | 1 | 1998 | 787 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2012 | 145 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2012 | 194 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 2907 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3705 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2307 | 0.020 |
Why?
|
| Rabbits | 2 | 1996 | 4772 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22029 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 270 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2014 | 859 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1994 | 459 | 0.020 |
Why?
|
| Curriculum | 1 | 2004 | 3717 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1992 | 439 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2011 | 146 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1994 | 582 | 0.020 |
Why?
|
| Archaea | 1 | 1990 | 58 | 0.020 |
Why?
|
| Microcephaly | 1 | 1994 | 425 | 0.020 |
Why?
|
| Arylsulfatases | 1 | 1990 | 11 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1713 | 0.020 |
Why?
|
| Cytosine | 1 | 2011 | 210 | 0.020 |
Why?
|
| Sulfatases | 1 | 1990 | 44 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1743 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 451 | 0.020 |
Why?
|
| Aotus trivirgatus | 1 | 1989 | 36 | 0.020 |
Why?
|
| Cebidae | 1 | 1989 | 21 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2016 | 3096 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12096 | 0.020 |
Why?
|
| Choroideremia | 1 | 1989 | 27 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4257 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1989 | 76 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1989 | 61 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12951 | 0.020 |
Why?
|
| Chimera | 2 | 2004 | 452 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1659 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3774 | 0.020 |
Why?
|
| Health Promotion | 1 | 2001 | 2204 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Body Height | 1 | 1995 | 1567 | 0.020 |
Why?
|
| Body Size | 1 | 2011 | 462 | 0.020 |
Why?
|
| RNA Probes | 1 | 2008 | 111 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2012 | 567 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 802 | 0.020 |
Why?
|
| Uveal Diseases | 1 | 1988 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1988 | 246 | 0.020 |
Why?
|
| Prostate | 1 | 2016 | 1791 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2635 | 0.020 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2007 | 13 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1988 | 130 | 0.020 |
Why?
|
| Apoptosis | 3 | 2011 | 9468 | 0.020 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 1 | 2007 | 15 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2015 | 3530 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1477 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 730 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1812 | 0.020 |
Why?
|
| Brain | 3 | 2023 | 26947 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1988 | 377 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 1629 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 489 | 0.020 |
Why?
|
| Registries | 2 | 2015 | 8175 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1986 | 49 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 2000 | 168 | 0.020 |
Why?
|
| Enzymes | 1 | 2007 | 258 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2007 | 595 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 2275 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 317 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9650 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1332 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1263 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2017 | 80168 | 0.020 |
Why?
|
| Epididymis | 1 | 2007 | 227 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 475 | 0.020 |
Why?
|
| Automation | 1 | 2007 | 580 | 0.020 |
Why?
|
| Placenta | 1 | 1994 | 1702 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1610 | 0.010 |
Why?
|
| Dwarfism | 2 | 1995 | 137 | 0.010 |
Why?
|
| Neurons | 2 | 2014 | 9416 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2007 | 832 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1987 | 480 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 564 | 0.010 |
Why?
|
| Cloning, Organism | 1 | 2003 | 50 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1984 | 686 | 0.010 |
Why?
|
| Asia | 1 | 2004 | 616 | 0.010 |
Why?
|
| Bacteriophage lambda | 1 | 1982 | 142 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 342 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1984 | 187 | 0.010 |
Why?
|
| Epilepsy | 1 | 1997 | 3269 | 0.010 |
Why?
|
| Seizures | 1 | 1994 | 2919 | 0.010 |
Why?
|
| Hippocampus | 1 | 2014 | 3736 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4738 | 0.010 |
Why?
|
| Middle Aged | 3 | 2014 | 219568 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2001 | 279 | 0.010 |
Why?
|
| Cricetulus | 1 | 1982 | 815 | 0.010 |
Why?
|
| Adolescent | 7 | 1995 | 87892 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 458 | 0.010 |
Why?
|
| Breast | 1 | 2009 | 1963 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3664 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3432 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2004 | 719 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16886 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 435 | 0.010 |
Why?
|
| Muscles | 1 | 1984 | 1579 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3533 | 0.010 |
Why?
|
| Callithrix | 1 | 1999 | 93 | 0.010 |
Why?
|
| Birth Weight | 1 | 2007 | 2097 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 841 | 0.010 |
Why?
|
| Canada | 1 | 2004 | 2111 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 869 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14641 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 2003 | 770 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2646 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2001 | 1647 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2001 | 563 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1128 | 0.010 |
Why?
|
| Europe | 1 | 2004 | 3420 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2004 | 1321 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5331 | 0.010 |
Why?
|
| Lymphocytes | 3 | 1992 | 2610 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1958 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 420 | 0.010 |
Why?
|
| Counseling | 1 | 2004 | 1541 | 0.010 |
Why?
|
| Leukocytes | 1 | 1984 | 2025 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4106 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1995 | 293 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2007 | 2496 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 294 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 13276 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1185 | 0.010 |
Why?
|
| Lac Operon | 1 | 1994 | 237 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 7502 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 830 | 0.010 |
Why?
|
| Epitopes | 1 | 2000 | 2502 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 574 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8650 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1994 | 987 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1994 | 865 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 168218 | 0.010 |
Why?
|
| Steryl-Sulfatase | 1 | 1990 | 11 | 0.010 |
Why?
|
| Quail | 1 | 1990 | 40 | 0.010 |
Why?
|
| Columbidae | 1 | 1990 | 40 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12604 | 0.010 |
Why?
|
| Gonadal Dysgenesis, Mixed | 1 | 1989 | 7 | 0.010 |
Why?
|
| Oncogenes | 1 | 1995 | 1220 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1989 | 115 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1987 | 10171 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 455 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58683 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8143 | 0.000 |
Why?
|
| Finland | 1 | 1989 | 603 | 0.000 |
Why?
|
| Telomere | 1 | 1994 | 931 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1989 | 310 | 0.000 |
Why?
|
| Lod Score | 1 | 1988 | 602 | 0.000 |
Why?
|
| Information Systems | 1 | 1989 | 397 | 0.000 |
Why?
|
| Iceland | 1 | 1987 | 184 | 0.000 |
Why?
|
| Temperature | 1 | 1993 | 2219 | 0.000 |
Why?
|
| Metaphase | 1 | 1986 | 144 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20055 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2009 | 54137 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15785 | 0.000 |
Why?
|
| South Africa | 1 | 1988 | 1821 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1988 | 1264 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1987 | 1368 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 5490 | 0.000 |
Why?
|